Dynavax Technologies | Bienes



Assets Cambio Fecha
AbbVie USD 135.16B 8.26B 2024-12
Adma Biologics USD 488.68M 98.06M 2024-12
Amgen USD 89.37B 2.47B 2025-03
AstraZeneca USD 106.25B 2.22B 2025-03
Biogen USD 28.03B 16.2M 2025-03
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Dynavax Technologies USD 986.26M 75.73M 2024-12
Gilead Sciences USD 56.43B 2.56B 2025-03
Glaxosmithkline GBP 59.46B 1.41B 2024-12
Merck USD 115.12B 1.98B 2025-03
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 208.03B 5.37B 2025-03
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Sarepta Therapeutics USD 3.96B 363.24M 2024-12
TG Therapeutics USD 577.69M 8.32M 2024-12
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



Dynavax Technologies Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.